https://www.selleckchem.com/pr....oducts/deferiprone.h
Patients who had myopia, astigmatism, glaucoma, cataract, etc. prior to their KD diagnosis were excluded. The age range was 0 to 6 years old. According to the cumulative curves, our results demonstrated that the myopic incidence in the IVIG group was significantly lower than the aspirin group (hazard ratio 0.59, 95% confidence intervals 0.36~0.96, p = 0.02). Treatment with IVIG for KD patients may have benefit for myopia control. Conclusion Compared to aspirin, IVIG may decrease the myopic risk in KD patients. However, it needs furt
Like
Comment
Share
